Bronchodilator responsiveness of peripheral airways in smokers with normal spirometry

Respirology

Volumn 21, Issue 7, 2016, Pages 1270-1276

  Jetmalani, Kanika ^a,b   Chapman, David G ^a,b,c   Thamrin, Cindy ^a,b   Farah, Claude S ^a,b,d   Berend, Norbert ^a,b,e   Salome, Cheryl M ^a,b   King, Gregory G ^a,b,f  

^a WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^d ANZAC Research Institute   (Australia)

^e George Institute of Global Health   (Australia)

^f ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

chronic obstructive pulmonary disease; inflammation; respiratory structure and function; tobacco; ventilation

Indexed keywords

IPRATROPIUM BROMIDE; SALBUTAMOL;

ACINAR AIRWAY; ADULT; AIRWAY SMOOTH MUSCLE; ARTICLE; BRONCHUS TONE; CONDUCTIVE AIRWAY; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN EXPERIMENT; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; MULTIPLE BREATH NITROGEN WASHOUT; PRIORITY JOURNAL; SMOKING; SMOOTH MUSCLE; SMOOTH MUSCLE TONE; SPIROMETRY;

EID: 84987621897     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12802     Document Type: Article

References (37)

1. Global Initiative for Chronic Obstructive Lung disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. Available from URL: http://wwwgoldcopdorg/. 2013
2. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax 2006; 61: 935–9.
3. Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N. Engl. J. Med. 1974; 291: 755–8.
4. McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, Wright AC, Gefter WB, Litzky L, Coxson HO et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N. Engl. J. Med. 2011; 365: 1567–75.
5. Macklem PT, Mead J. Resistance of central and peripheral airways measured by a retrograde catheter. J. Appl. Physiol. 1967; 22: 395–401.
6. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N. Engl. J. Med. 1968; 278: 1355–60.
7. Verbanck S, Schuermans D, Meysman M, Paiva M, Vincken W. Noninvasive assessment of airway alterations in smokers. Am. J. Respir. Crit. Care Med. 2004; 170: 414–9.
8. Robinson PD, Goldman MD, Gustafsson PM. Inert gas washout: theoretical background and clinical utility in respiratory disease. Respiration 2009; 78: 339–55.
9. Robinson P, Latzin P, Verbanck S, Hall GL, Horsley A, Gappa M, Thamrin C, Arets HGM, Aurora P, Fuchs S et al. Thompson B and Gustafsson PM. Consensus statement for inert gas washout measurement using multiple and single breath tests. Eur. Respir. J. 2013; 41: 507–22.
10. Verbanck S, Schuermans D, Noppen M, Van Muylem A, Paiva M, Vincken W. Evidence of acinar airway involvement in asthma. Am. J. Respir. Crit. Care Med. 1999; 159: 1545–50.
11. Wright JL, Sun JP, Churg A. Cigarette smoke exposure causes constriction of rat lung. Eur. Respir. J. 1999; 14: 1095–99.
12. Brusasco V. Reducing cholinergic constriction: the major reversible mechanism in COPD. Eur. Respir. Rev. 2006; 15: 32–6.
13. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MSM, Zheng J et al. Multi-ethnic reference values for spirometry for the 3–95 year age range: the global lung function 2012 equations: report of the global lung function initiative (GLI), ERS task force to establish improved lung function reference values. Eur. Respir. J. 2012; 40: 1324–43.
14. Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur. Respir. J. 2005; 26: 720-35.
15. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P et al. Standardisation of spirometry. Eur. Respir. J. 2005; 26: 319–38.
16. Crapo RO, Morris AH. Standardized single breath normal values for carbon monoxide diffusing capacity. Am. Rev. Respir. Dis. 1981; 123: 185–89.
17. Crapo RO, Morris AH, Clayton PD, Nixon CR. Lung volumes in healthy nonsmoking adults. Bull. Eur. Physiopathol. Respir. 1982; 18: 419–25.
18. Harvey B-G, Strulovici-Barel Y, Kaner RJ, Sanders A, Vincent TL, Mezey JG, Crystal RG. Risk of copd with obstruction in active smokers with normal spirometry and reduced diffusion capacity. Eur. Respir. J. 2015; 46: 1589–97.
19. Verbanck S, Schuermans D, Van Muylem A, Melot C, Noppen M, Vincken W, Paiva M. Conductive and acinar lung-zone contributions to ventilation inhomogeneity in COPD. Am. J. Respir. Crit. Care Med. 1998; 157: 1573–77.
20. Downie SR, Salome CM, Verbanck S, Thompson B, Berend N, King GG. Ventilation heterogeneity is a major determinant of airway hyperresponsiveness in asthma, independent of airway inflammation. Thorax 2007; 62: 684–89.
21. Verbanck S, Schuermans D, Paiva M, Meysman M, Vincken W. Small airway function improvement after smoking cessation in smokers without airway obstruction. Am. J. Respir. Crit. Care Med. 2006; 174: 853–57.
22. Verbanck S, Thompson B, Schuermans D, Kalsi H, Biddiscombe M, Stuart-Andrews C, Hanon S, Van Muylem A, Paiva M, Vincken W et al. Ventilation heterogeneity in the acinar and conductive zones of the normal ageing lung. Thorax 2012; 67: 789–95.
23. De Jongste JC, Mons H, Bonta IL, Kerrebijn KF. Relaxation of human peripheral airway smooth muscle in vitro does not correlate with severity of chronic airflow limitation in vivo. Pulm. Pharmacol. 1989; 2: 75–9.
24. Berger P, Laurent F, Begueret H, Perot V, Rouiller R, Raherison C, Molimard M, Marthan R, Tunon-de-Lara JM. Structure and function of small airways in smokers: relationship between air trapping at CT and airway inflammation. Radiology 2003; 228: 85–94.
25. Fixman ED, Tolloczko B, Lauzon AM. In: Hamid Q, Shannon J, Martin J (eds) Aiway Smooth Muscle: The Contractile Phenotype in Physiologic Basis of Respiratory Disease. BC Decker Inc., Hamilton, Ontario, Canada, 2005.
26. Dolhnikoff M, Morin J, Ludwig MS. Human lung parenchyma responds to contractile stimulation. Am. J. Respir. Crit. Care Med. 1998; 158: 1607–12.
27. Dobbs LG, Mason RJ. Pulmonary alveolar type II cells isolated from rats. Release of phosphatidylcholine in response to beta-adrenergic stimulation. J. Clin. Invest. 1979; 63: 378–87.
28. Abboud RT, Fera T, Johal S, Richter A, Gibson N. Effect of smoking on plasma neutrophil elastase levels. J. Lab. Clin. Med. 1986; 108: 294–300.
29. Hunninghake GW, Crystal RG. Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers. Am. Rev. Respir. Dis. 1983; 128: 833–88.
30. Kuschner W, D'Alessandro A, Wong H, Blanc P. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur. Respir. J. 1996; 9: 1989–94.
31. Van der Vaart H, Postma DS, Timens W, ten Hacken NH. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 2004; 59: 713–21.
32. Vitalis T, Kern I, Croome A, Behzad H, Hayashi S, Hogg J. The effect of latent adenovirus 5 infection on cigarette smoke-induced lung inflammation. Eur. Respir. J. 1998; 11: 664–9.
33. Montuschi P, Collins JV, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov SA, Barnes PJ. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am. J. Respir. Crit. Care Med. 2000; 162: 1175–7.
34. Chiba Y, Murata M, Ushikubo H, Yoshikawa Y, Saitoh A, Sakai H, Kamei J, Misawa M. Effect of cigarette smoke exposure in vivo on bronchial smooth muscle contractility in vitro in rats. Am. J. Respir. Cell Mol. Biol. 2005; 33: 574–81.
35. Hartiala JJ, Mapp C, Mitchell RA, Gold WM. Nicotine-induced respiratory effects of cigarette smoke in dogs. J. Appl. Physiol. 1985; 59: 64–71.
36. Hanania NA, Sharafkhaneh A, Celli B, Decramer M, Lystig T, Kesten S, Tashkin D. Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial. Respir. Res. 2011; 12: 1465–9921.
37. Calverley PMA, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003; 58: 659–64.